Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Thanks for sharing. Leo gave evidence to several shareholders to use in a class action lawsuit if he lied, as suggested by some critics.

Otezla's Phase 2 trial ended in August 2009 and Celgene reported results on December 15, 2009. That was about 4.5 months.

If we use Otezla’s timeline to estimate Prurisol, the trial ended on December 21, 2017. 4.5 months later will be early May.

His response yesterday is that "the company does not have the Prurisol results yet."